Novartis Czech Republic`s ROCE reached 5.67 % in 2017. This is 19.6 % less than in the previous year.
Buy annual subscriptions for all our products.
| Company | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | % | ... | ... | ... | ... | ... | 48.3 | 26.3 | 33.8 | 44.9 | 36.6 | |||||||
| Bayer Czech Republic | % | ... | ... | ... | 170 | 27.1 | 26.9 | 28.9 | 29.0 | |||||||||
| GlaxoSmithKline Czech Republic | % | ... | ... | ... | 14.3 | 9.26 | 6.91 | 5.65 | 11.2 | |||||||||
| Merck Czech Republic | % | ... | ... | 13.7 | 14.8 | 5.72 | 7.46 | 15.7 | ||||||||||
| Novartis Czech Republic | % | 7.85 | 8.64 | 5.36 | 7.06 | 8.58 | ||||||||||||
| Pfizer Czech Republic | % | ... | ... | 13.9 | 4.56 | 18.1 | 16.1 | 7.83 | ||||||||||
| Roche Czech Republic | % | ... | ... | ... | 4.01 | 3.25 | 8.93 | 5.39 | 2.65 | ... | ||||||||
| Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 2.97 | 2.37 | 3.65 | 0.083 | 4.39 | ||||||||
| Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 31.4 | 27.0 | 21.3 | ||
| Walmark | % | ... | ... | ... | 16.0 | -0.246 | -0.742 | 3.56 | -56.9 |
Helgi Library 
